cardinal health inc shares cah slumped 45 in premarket trade thursday after the drug distributor missed profit estimates for the second quarte and announced a leadership change the company posted net income of 138 million or 50 cent a share for the quarter up from 116 million or 40 cents a share in the yearearlier period adjusted pershare earnings came to 105 below the 117 factset consensus revenue rose 11 to 47103 billion from 42586 billion a year ago ahead of the 44714 billion factset consensus earnings included a 303 million noncash pretax goodwill impairment charge in the medical segment in fiscal year 2022 medical segment performance was significantly impacted by inflation and supply chain constraints said mike kaufmann ceo of cardinal health in addition the pharmaceutical segment grew 5 and we generated strong cash flow returning 16 billion to our shareholders through share repurchases and dividends the company is now expecting fiscal 2023 adjusted eps of 505 to 540 compared with a factset consensus of 537 separately the company said ceo kaufmann is leaving the company and the board and will be replaced by jason hollar currently cfo it named patricia english currently chief accounting officer as interim ceo shares have gained 22 in the year to date while the sp 500 spx has fallen 12